Author | Robert Andtbacka, MD | OncLive

Author | Robert Andtbacka, MD

Articles

Dr. Andtbacka Discusses Next Steps With T-VEC in Melanoma

April 14, 2018

Video

Robert Andtbacka, MD, associate professor in the Division of Surgical Oncology, Department of Surgery at the University of Utah School of Medicine, discusses the future of talimogene laherparapvec (T-VEC; Imlygic) in the treatment of patients with melanoma.

Dr. Andtbacka Discusses Combination Therapy in Melanoma

March 23, 2018

Video

Robert Andtbacka, MD, associate professor in the Division of Surgical Oncology, Department of Surgery at the University of Utah School of Medicine, discusses combination therapy in melanoma.

Dr. Andtbacka Discusses the Role of T-VEC in Melanoma

February 24, 2018

Video

Robert Andtbacka, MD, associate professor in the Division of Surgical Oncology, Department of Surgery at the University of Utah School of Medicine, discusses the role of talimogene laherparapvec (T-VEC; Imlygic) in the treatment of patients with melanoma.

Dr. Andtbacka on the OPTiM Results of T-VEC for Melanoma

June 30, 2017

Video

Robert Andtbacka, MD, associate professor in the Division of Surgial Oncology, Department of Surgery at the University of Utah School of Medicine, discusses the long-term follow-up of overall survival data from the phase III OPTiM study of taglimogene laherparepvec (T-VEC) for patients with metastatic melanoma.

x